Mark Devlin
Corporate Officer/Principal presso AMPLIA THERAPEUTICS LIMITED
Profilo
Mark Devlin is currently working as a Scientific Adviser at Amplia Therapeutics Ltd.
Previously, he held positions as the Chief Executive Officer at CTxONE, the Chief Operating Officer at Cancer Therapeutics CRC Pty Ltd., and an Associate Professor at Peter MacCallum Cancer Institute.
Dr. Devlin has an MBA from Melbourne Business School and a doctorate from the University of Melbourne.
Posizioni attive di Mark Devlin
| Società | Posizione | Inizio |
|---|---|---|
| AMPLIA THERAPEUTICS LIMITED | Corporate Officer/Principal | - |
Precedenti posizioni note di Mark Devlin
| Società | Posizione | Fine |
|---|---|---|
Cancer Therapeutics CRC Pty Ltd.
 Cancer Therapeutics CRC Pty Ltd. BiotechnologyHealth Technology Cancer Therapeutics CRC Pty Ltd. engages in research and development novel oncology drug and clinical diseases. It focuses in recombinant protein production, structural biology, DMPK, and translational cancer biology. The company was founded in 2007 and is headquartered in Melbourne, Australia. | Chief Operating Officer | 01/09/2019 |
Peter MacCallum Cancer Institute
 Peter MacCallum Cancer Institute General GovernmentGovernment Peter MacCallum Cancer Institute is a world-renowned cancer research, education, and treatment center. The non-profit company is based in Melbourne, Australia. The institute is dedicated to providing care for individuals affected by cancer. | Corporate Officer/Principal | 01/09/2019 |
| CTxONE | Chief Executive Officer | - |
Formazione di Mark Devlin
| Melbourne Business School | Masters Business Admin |
| University of Melbourne | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| AMPLIA THERAPEUTICS LIMITED | Health Technology |
| Aziende private | 3 |
|---|---|
Cancer Therapeutics CRC Pty Ltd.
Cancer Therapeutics CRC Pty Ltd. BiotechnologyHealth Technology Cancer Therapeutics CRC Pty Ltd. engages in research and development novel oncology drug and clinical diseases. It focuses in recombinant protein production, structural biology, DMPK, and translational cancer biology. The company was founded in 2007 and is headquartered in Melbourne, Australia. | Health Technology |
Peter MacCallum Cancer Institute
Peter MacCallum Cancer Institute General GovernmentGovernment Peter MacCallum Cancer Institute is a world-renowned cancer research, education, and treatment center. The non-profit company is based in Melbourne, Australia. The institute is dedicated to providing care for individuals affected by cancer. | Government |
| CTxONE |
- Borsa valori
- Insiders
- Mark Devlin
